| Role of nitric oxide on motor behavior EAD Bel, FS Guimaraes, M Bermũdez-Echeverry, MZ Gomes, ... Cellular and molecular neurobiology 25 (2), 371-392, 2005 | 144 | 2005 |
| Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease M Bortolanza, R Cavalcanti-Kiwiatkoski, FE Padovan-Neto, CA da-Silva, ... Neurobiology of disease 73, 377-387, 2015 | 120 | 2015 |
| Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington’s Disease Models V Beaumont, S Zhong, H Lin, WJ Xu, A Bradaia, E Steidl, M Gleyzes, ... Neuron, 2016 | 110 | 2016 |
| Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease FE Padovan-Neto, MB Echeverry, V Tumas, EA Del-Bel Neuroscience 159 (3), 927-935, 2009 | 105 | 2009 |
| Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by l-DOPA? M Bortolanza, FE Padovan-Neto, R Cavalcanti-Kiwiatkoski, ... Phil. Trans. R. Soc. B 370 (1672), 20140190, 2015 | 58 | 2015 |
| Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats FE Padovan-Neto, R Cavalcanti-Kiwiatkoviski, ROG Carolino, ... Neuropharmacology, 2014 | 54 | 2014 |
| Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment E Del-Bel, F Eduardo Padovan-Neto, R Raisman-Vozari, M Lazzarini Current pharmaceutical design 17 (5), 471-488, 2011 | 53 | 2011 |
| Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP … FE Padovan-Neto, S Sammut, S Chakroborty, AM Dec, S Threlfell, ... The Journal of Neuroscience 35 (14), 5781-5791, 2015 | 51 | 2015 |
| Nitric oxide synthase inhibitor improves de novo and long-term L-DOPA-induced dyskinesia in hemiparkinsonian rats FE Padovan-Neto, MB Echeverry, S Chiavegatto, E Del-Bel Frontiers in systems neuroscience 5, 2011 | 51 | 2011 |
| Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/DeltaFosB expression FE Padovan-Neto, NR Ferreira, D Tavares, D de Aguiar, CA Silva, ... Neuroscience Letters, 2013 | 36 | 2013 |
| Counteraction by Nitric Oxide Synthase Inhibitor of Neurochemical Alterations of Dopaminergic System in 6-OHDA-Lesioned Rats Under l-DOPA Treatment E Del-Bel, FE Padovan-Neto, RE Szawka, CA da-Silva, ... Neurotoxicity research, 1-12, 2013 | 33 | 2013 |
| Investigations into Potential Extrasynaptic Communication between the Dopaminergic and Nitrergic Systems M Mitkovski, FE Padovan-Neto, R Raisman-Vozari, L Ginestet, C Da-Silva, ... Frontiers in Physiology 3, 372, 2012 | 32 | 2012 |
| Age-and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease FE Padovan-Neto, L Jurkowski, C Murray, GE Stutzmann, M Kwan, ... Nitric Oxide 83, 40-50, 2019 | 26 | 2019 |
| Nitric Oxide, a new player in L-DOPA-induced dyskinesia? E Del-Bel, FE Padovan-Neto, M Bortolanza, V Tumas, JAS Aguiar, ... Frontiers in bioscience (Elite edition) 7, 193-221, 2014 | 26 | 2014 |
| Selective regulation of 5-HT1B serotonin receptor expression in the striatum by dopamine depletion and repeated L-DOPA treatment: Relationship to L-DOPA-induced dyskinesias FE Padovan-Neto, S Patterson, NMF Voelkner, F Altwal, JA Beverley, ... Molecular neurobiology 57 (2), 736-751, 2020 | 23 | 2020 |
| Disturbance of sensorimotor filtering in the 6-OHDA rodent model of Parkinson's disease AC Issy, FE Padovan-Neto, M Lazzarini, M Bortolanza, E Del-Bel Life sciences 125, 71-78, 2015 | 22 | 2015 |
| Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats N Novaretti, FE Padovan-Neto, V Tumas, CA Da-Silva, EA Del Bel Brazilian Journal of Medical and Biological Research 43 (11), 1047-1053, 2010 | 21 | 2010 |
| Regulation of Striatal Neuron Activity by Cyclic Nucleotide Signaling and Phosphodiesterase Inhibition: Implications for the Treatment of Parkinson’s Disease FE Padovan-Neto, AR West Phosphodiesterases: CNS Functions and Diseases, 257-283, 2017 | 19 | 2017 |
| Repurposing an established drug: an emerging role for methylene blue in L‐DOPA‐induced dyskinesia K Bariotto‐dos‐Santos, FE Padovan‐Neto, M Bortolanza, ... European Journal of Neuroscience, 2018 | 18 | 2018 |
| Neurotransmissão g ansmissão g ansmissão glutamatérgica e plasticidade sináptica: aspectos mo-leculares, clínicos ef línicos ef línicos e filogenéticos RN Ruggiero, LS Bueno-Júnior, JB de Ross, HA Fachim, ... Medicina (Ribeirão Preto) 44 (2), 143-56, 2011 | 18* | 2011 |